Nautilus Biotechnology
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Nautilus Biotechnology's balance sheet done over the years? Its assets were worth $305,565,000 last year, which is less than in the previous period. 13% of Nautilus Biotechnologyโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $40,212,000, which means an increase by 14% compared compared to last year.

Debt to Assets

Nautilus Biotechnology, Inc. (NASDAQ:NAUT): Debt to assets
2018 145820556 140.82M 96.57%
2019 18542000 490K 2.64%
2020 85011000 114.73M 134.96%
2021 398450000 34.87M 8.75%
2022 350052000 35.12M 10.04%
2023 305565000 40.21M 13.16%

NAUT Balance Sheet (2018 โ€“ 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
19.39M114.52M185.61M36.60M595K1.19M
Short term investments
154.02M69.94M160.11M40.13M16.06M144.48B
Net receivables
000000
Inventory
000000
Other current assets
3.41M2.73M3.49M917K305K-144.48B
Total current assets
176.83M187.20M349.22M77.65M16.96M1.33M
Non-current assets:
Property, Plant and Equipment
36.90M32.56M31.86M6.21M1.11M0
Goodwill
000000
Intangible assets
000000
Long term investments
90.64M129.16M16.37M612K147.84M144.48M
Other non-current assets
1.18M1.10M997K527K-147.38M0
Total non-current assets
128.72M162.84M49.22M7.35M1.57M144.48M
Total assets
305.56M350.05M398.45M85.01M18.54M145.82M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
-948K02.73M936K00
Short term debt
7.07M1.99M970K1.47M00
Total current liabilities
9.12M6.79M5.81M3.01M490K5K
Non-current liabilities:
Long term debt
31.09M28.33M29.06M3.29M275M5M
Deferred tax
000000
Other non-current liabilities
000108.41M00
Total non-current liabilities
31.09M28.33M29.06M111.71M275M5M
Total liabilities
40.21M35.12M34.87M114.73M490K140.82M
Data sourceData sourceData sourceData sourceData sourceData source